Skip to search.
 TSX Down 1.30% TSX Ventures Down 1.82%

Marina Biotech, Inc. (MRNA)

-Other OTC
0.41 Down 0.04(7.80%) Jul 27, 3:57PM EDT
|Pre-Market : 0.71 Down 0.01 (1.43%) 4:33PM EST - Nasdaq Real Time Price
Add to Portfolio
Prev Close:0.45
Open:0.42
Bid:N/A
Ask:N/A
1y Target Est:4.00
Beta:2.02
Next Earnings Date:N/A
Day's Range:0.40 - 0.44
52wk Range:0.40 - 1.30
Volume:195,291
Avg Vol (3m):63,878
Market Cap:10.64M
P/E (ttm):1.58
EPS (ttm):0.26
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
MRNADown 7.80%10.64M
ALNYDown 0.62%10.86B
AZNDown 0.52%41.35B
NVSDown 0.26%245.24B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):23.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Marina Biotech, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of nucleic acid-based therapies to treat orphan diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback